FDA Inspection 1149010 — HomeChoice Partners dba BioScript Infusion Services
The FDA completed an inspection of HomeChoice Partners dba BioScript Infusion Services on August 9, 2021 in Augusta, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 9, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Augusta, GA (United States)